Storia: Trump's generic drugs tariff threatens Indian pharma's top market

WARPTECHNEWS · LAB

Trump ⁠has been pressuring drugmakers through his most-favored-nation drug pricing policy to lower prices to what people pay in other high-income countries.

Trump's generic drugs tariff threatens Indian pharma's top market

Confronto fonti

Trump's generic drugs tariff threatens Indian pharma's top market

Timeline cronologica

Trump announces 0% tariff on generic medicines for two years; 200% thereafter

Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%

Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?

US tariffs could raise drug prices, squeeze Indian generics

0, 100, 200: How Trump's latest generic medicines tariffs could affect India

US proposal to impose steep tariffs on generic medicines could significantly impact India: GTRI

Trump threatens tariff on generic medicines: Should India be worried?

US to impose steep tariffs on generic medicine imports from Aug 2028

Trump announces 100% tariffs on imported generic pharmaceutical drugs

Why these 8 stocks including Pharma majors will remain in focus on today following Trump’s tariff announcement

Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028

Trump threatens tariff on generic medicines: Should India be worried?

Trump’s 100% Generic Drug Duty Threatens US Low-Cost Supply

0, 100, 200: How Trump's latest generic medicines tariffs could affect India

Pharma stocks bleed after Trump announces up to 200% tariff on generic drugs; Aurobindo, Sun Pharma & Cipla slide over 3%

Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% storm

Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?

Trump’s 100% generic drug duty threatens US low-cost supply

200% Trump tariff shock? India’s cheap pills may still beat US rivals

Indian pharma firms may yet survive Trump's 200% tariff bombshell

Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investors

Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive

Trump announces plan for 200% tariffs on imported generic drugs

US proposal to impose steep tariffs on generic medicines could significantly impact India: GTRI

Trump's generic drugs tariff threatens Indian pharma's top market